Paramjit Sawhney - Mega Lifesciences President of International

All Insiders . Thailand . 
Stock . Mega Lifesciences Public . Stakeholders . Insider . Paramjit Sawhney
MEGA Stock  THB 34.75  0.25  0.71%   

President

Paramjit Sawhney is President of International of Mega Lifesciences Public since 2000.
Age 60
Tenure 24 years
Phone66 2 769 4222
Webhttps://www.megawecare.com

Mega Lifesciences Management Efficiency

The company has return on total asset (ROA) of 0.1239 % which means that it generated a profit of $0.1239 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2915 %, meaning that it generated $0.2915 on every $100 dollars invested by stockholders. Mega Lifesciences' management efficiency ratios could be used to measure how well Mega Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.
Mega Lifesciences Public has accumulated 1.23 B in total debt with debt to equity ratio (D/E) of 21.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mega Lifesciences Public has a current ratio of 1.67, which is within standard range for the sector. Debt can assist Mega Lifesciences until it has trouble settling it off, either with new capital or with free cash flow. So, Mega Lifesciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mega Lifesciences Public sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mega to invest in growth at high rates of return. When we think about Mega Lifesciences' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

PRESIDENT Age

Weerapun UngsumaleeHome Product Center
60
Vathunyu VisuthikosolHome Product Center
59
Kosin ChantikulMinor International Public
41
Nitat AroontippaitoonHome Product Center
58
Somsri RuchdaponkulMinor International Public
59
Kessara WongsekateBangkok Dusit Medical
N/A
Poramaporn PrasarttongOsothBangkok Dusit Medical
48
Narumol NoiamBangkok Dusit Medical
65
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast moving consumer goods. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited. MEGA LIFESCIENCES operates under Drug Manufacturers - Major classification in Thailand and is traded on Stock Exchange of Thailand. Mega Lifesciences Public (MEGA) is traded on Thailand Exchange in Thailand and employs 21 people.

Management Performance

Return On Equity0.29
Return On Asset0.12

Mega Lifesciences Public Leadership Team

Elected by the shareholders, the Mega Lifesciences' board of directors comprises two types of representatives: Mega Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mega. The board's role is to monitor Mega Lifesciences' management team and ensure that shareholders' interests are well served. Mega Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mega Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Duangnapa Tongsiri, Pres Thailand
Apichai Chanjarusiri, Manufacturing Thailand
Vivek Dhawan, CEO, Chief Coach, Director and Member of Remuneration and Nomination Committee
Manoj Gurbuxani, Deputy Officer
Thomas Abraham, CFO and Director
Deepak Panjwani, Chief Officer
Paramjit Sawhney, President of International
Sujintana Boonworapat, Co Sec
Girish Wadhwa, Managing Director of Myanmar

Mega Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mega Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.29
Return On Asset0.12
Profit Margin0.15 %
Operating Margin0.17 %
Current Valuation38.59 B
Shares Outstanding871.87 M
Shares Owned By Insiders60.85 %
Shares Owned By Institutions7.67 %
Price To Book4.70 X
Price To Sales2.68 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Mega Stock

Mega Lifesciences financial ratios help investors to determine whether Mega Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mega with respect to the benefits of owning Mega Lifesciences security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY